Development of Immunogenic Tumor-Loaded Dendritic Cells Through Physical Perturbation and Apoptotic Cell Loading

REFERENCES

• Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.-H., Pulendran B., Palucka K. Immunobiology of dendritic cells. Ann. Rev. Immunol. 2000; 18: 767–811
   PubMed Web of Science ®Google Scholar
• Berard F., Blanco P., Davoust J., Neidhart-Berard E.M., Nouri-Shirazi M., Taquet N., Rimoldi D., Cerottini J.C., Banchereau J., Palucka A.K. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med. 2000; 192: 1535–1544
   PubMed Web of Science ®Google Scholar
• Berger C., Xu A., Hanlon D., Lee C., Schechner J., Glusac E., Christensen I., Snyder E., Holloway V., Tigelaar R., Edelson R. Induction of human tumor-loaded dendritic cells. Inter. J. Cancer 2001a; 4: 438–447
   Web of Science ®Google Scholar
• Berger C.L., Hanlon D., Kanada D., Girardi M., Edelson R.L. Transimmunization, a novel approach for tumor immunotherapy. Trans. Apher. Sci. 2002; 26: 205–216
   PubMed Web of Science ®Google Scholar
• Berger C.L., Tigelaar R., Cohen J., Mariwalla K., Trinh J., Wang N., Edelson R. L. Cutaneous T cell lymphoma, malignant proliferation of T-regulatory cells. Blood 2005; 105: 1640–1647
   PubMed Web of Science ®Google Scholar
• Berger C.L., Xu A.L., Hanlon D., Lee C., Schechner J., Glusac E., Christensen I., Snyder E., Holloway V., Tigelaar R., Edelson R.L. Induction of human tumor-loaded dendritic cells. Int. J. Cancer 2001b; 91: 438–447
   PubMed Web of Science ®Google Scholar
• Chen Y., Yang C., Jin N., Xie Z., Tang Y., Fei L., Jia Z., Wu Y. Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization. Eur. J. Immunol. 2007; 37: 167–176
   PubMedGoogle Scholar
• Cools N., Ponsaerts P., Van Tendeloo V., Berneman Z. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leuk. Biol. 2007; 82: 1–10
   PubMedGoogle Scholar
• Csomor E., Bajtay Z., Sandor N., Kristof K., Arlaud G., Thiel S., Erdei A. Complement protein C1q induces maturation of human dendritic cells. Mol. Immunol. 2007; 44: 3389–3397
   PubMed Web of Science ®Google Scholar
• Delamarre L., Holcombe H., Mellman I. Presentation of exogenous antigens on major histocompatability complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J.Exper. Med. 2003; 198: 111–122
   PubMed Web of Science ®Google Scholar
• Edelson R.L., Berger C.L., Gasparro F.P., Jegasothy B., Heald P., Wintroub B., Vonderheid E., Knobler R., Wolff K., Plewig G., McKiernan G., Christiansen I., Oster M., Honigsmann H., Wilford H., Kokoschka E., Rehle T., Perez M., Stingl G., Laroche L. Treatment of leukemic cutaneous T-cell lymphoma with extracorporeally-photoactivated 8-methoxypsoralen. New Engl. J. Med. 1987; 316: 297–303
   PubMed Web of Science ®Google Scholar
• Fong L., Engleman E. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 2000; 18: 245–273
   PubMed Web of Science ®Google Scholar
• Gallucci S., Lolkema M., Matzinger P. Natural adjuvants endogenous activators of dendritic cells. Nat. Med. 1999; 5: 1249–1255
   PubMed Web of Science ®Google Scholar
• Gallucci S., Matzinger P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 2001; 13: 114–119
   PubMed Web of Science ®Google Scholar
• Girardi M., Berger C., Wilson L., Christensen I., Thompson K., Glusac E., Edelson R. Transimmunization for cutaneous T cell lymphoma: a Phase I study. Leukema Lymphoma 2006; 47: 1495–1503
   PubMed Web of Science ®Google Scholar
• Heald P., Rook A., Perez M., Wintroub B., Knobler R., Jegasothy B., Gasparro F., Berger C., Edelson R. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J. Am. Acad. Dermatol. 1992; 27: 427–433
   PubMed Web of Science ®Google Scholar
• Hoffmann T. K., Meidenbauer N., Dworacki G., Kanaya H., Whiteside T. L. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res. 2000; 60: 3542–3549
   PubMed Web of Science ®Google Scholar
• Kim E. J., Hess S., Richardson S. K., Newton S., Showe L. C., Benoit B. M., Ubriani R., Vittorio C. C., Junkins-Hopkins J. M., Wysocka M., Rook A. H. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J. Clin. Invest. 2005; 115: 798–812
   PubMed Web of Science ®Google Scholar
• Liyanage U., Moore T., Joo H., Tanaka Y., Herrmann V., Doherty G., Drebin J., Strasberg S., Eberlein T., Goedegebuure P., Linehan D. Prevalance of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002; 169: 2756–2761
   PubMed Web of Science ®Google Scholar
• Masse D., Ebstein F., Bougras G., Harb J., Meflah K., Gregoire M. Increased expression of inducible HSP70 in apoptotic cells is correlated with their efficacy for antitumor vaccine therapy. Int. J. Cancer 2004; 111: 575–583
   PubMedGoogle Scholar
• Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106: 255–258
   PubMed Web of Science ®Google Scholar
• Mende I., Engleman E. Breaking tolerance to tumors with dendritic cell-based immunotherapy. Ann. N Y Acad. Sci. 2005; 1058: 96–104
   PubMedGoogle Scholar
• Pierre P., Turley S., Gatti E., Hull M., Meltzer J., Mirza A., Inaba K., Steinman R., Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997; 388: 787–792
   PubMed Web of Science ®Google Scholar
• Sallusto F., Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 2000; 177: 134–140
   PubMed Web of Science ®Google Scholar
• Shofner J., Vasquez J., Berger C., Edelson R. Improved generation of anti-tumor immunity by antigen dose limitation. J. Immune Based Ther. Vaccines 2007; 11186: 1476–8518, 5:2:DOI:10
   Google Scholar
• Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 2002; 99: 351–358
   PubMed Web of Science ®Google Scholar
• Steinman R.M., Turley S., Mellman I., Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000; 191: 411–416
   PubMed Web of Science ®Google Scholar
• Timmerman J.M., Levy R. Dendritic cell vaccines for cancer immunotherapy. Annu. Rev. Med. 1999; 50: 507–529
   PubMed Web of Science ®Google Scholar
• Wahl S., Chen W. Transforming growth factor-b-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res. Ther 2005; 7: 62–68
   PubMed Web of Science ®Google Scholar